Image guided intensity modulated hypofractionated radiotherapy in high-risk prostate cancer patients treated four or five times per week: analysis of toxicity and preliminary results-Reference-Cited by-同舟云学术

Image guided intensity modulated hypofractionated radiotherapy in high-risk prostate cancer patients treated four or five times per week: analysis of toxicity and preliminary results

Published:2014-09-26 Issue:1 Volume:9 Page:
ISSN:1748-717X
Container-title:Radiation Oncology
language:en
Short-container-title:Radiat Oncol

Author:

Valeriani Maurizio,Carnevale Alessia,Osti Mattia Falchetto,DE Sanctis Vitaliana,Agolli Linda,Maurizi Enrici Riccardo

Publisher

Springer Science and Business Media LLC

Subject

Radiology, Nuclear Medicine and imaging,Oncology

Link

http://link.springer.com/content/pdf/10.1186/1748-717X-9-214.pdf

Reference31 articles.

1. Bolla M, Collette L, Blank L, Warde P, Dubois JB, Mirimanoff RO, Storme G, Bernier J, Kuten A, Sternberg C, Mattelaer J, Lopez Torecilla J, Pfeffer JR, Lino Cutajar C, Zurlo A, Pierart M: Long-term results with immediate androgen suppression and external irradiation in patients with locally advanced prostate cancer (an EORTC study): a phase III randomised trial. Lancet 2002, 360: 103-106. 10.1016/S0140-6736(02)09408-4

2. Lawton CA, Winter K, Murray K, Machtay M, Mesic JB, Hanks GE, Coughlin CT, Pilepich MV: Updated results of the phase III Radiation Therapy Oncology Group (RTOG) trial 85–31 evaluating the potential benefit of androgen suppression following standard radiation therapy for unfavorable prognosis carcinoma of the prostate. Int J Radiat Oncol Biol Phys 2001, 49: 937-946. 10.1016/S0360-3016(00)01516-9

3. Fonteyne V, Villeirs G, Lumen N, De Meerleer G: Urinary toxicity after high dose intensity modulated radiotherapy as primary therapy for prostate cancer. Radiother Oncol 2009, 92: 42-47. 10.1016/j.radonc.2009.03.013

4. Fowler JF, Ritter MA, Chappell RJ, Brenner DJ: What hypofractionated protocols should be tested for prostate cancer? Int J Radiat Oncol Biol Phys 2003, 56: 1093-1104. 10.1016/S0360-3016(03)00132-9

5. Dubray BM, Thames HD: Chronic radiation damage in the rat rectum: an analysis of the influences of fractionation, time and volume. Radiother Oncol 1994, 33: 41-47. 10.1016/0167-8140(94)90084-1

Cited by 9 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Hypofractionation of radiation dose to the prostate does not necessarily imply a greater risk of acute radiation proctitis;Clinical and Translational Radiation Oncology;2023-11

2. Acute and late toxicity patterns of moderate hypo-fractionated radiotherapy for prostate cancer: A systematic review and meta-analysis;Clinical and Translational Radiation Oncology;2023-05

3. Meta-analysis of Elective Pelvic Nodal Irradiation Using Moderate Hypofractionation for High-Risk Prostate Cancer;International Journal of Radiation Oncology*Biology*Physics;2022-08

4. Technical Note: Three‐dimensional QA of simultaneous integrated boost radiotherapy treatments by a dose‐volume histogram methodology and its comparison with 3D gamma results;Medical Physics;2021-05-06

5. Elective Pelvic Nodal Irradiation With a Simultaneous Hypofractionated Integrated Prostate Boost for Localised Prostate Cancer: Ready for Prime Time?;Clinical Oncology;2020-03